Ionis Pharma's genetic disease drug succeeds in late-stage study
(Reuters) -Ionis Pharmaceuticals said on Monday its experimental drug reduced the occurrence of painful attacks in patients with a rare genetic disease ...
Stay updated with breaking news from Devika Syamnath. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Reuters) -Ionis Pharmaceuticals said on Monday its experimental drug reduced the occurrence of painful attacks in patients with a rare genetic disease ...
Spirit Airlines said on Friday it was assessing options to refinance its 2025 debt maturities amid some analyst concerns over the airline's ability to stay afloat. (Reporting by Abhijith Ganapavaram...
Four U.S. banks warned of lower interest income for this year on Friday, capping a week of dour commentary from the industry that has been under pressure from high deposit costs. After...
Still, a string of startups such as Reddit and ServiceTitan are looking to go public over the next few months, as dovish expectations around the Federal Reserve's interest rate trajectory encourages IPO hopefuls. Its share sale had fetched over $1 billion for its billionaire executives, co-founder Vyacheslav Kim and CEO Mikheil Lomtadze, as well as another shareholder, Asia Equity Partners.
Shares of Spirit shot up 18% to $6.73 in premarket trading, after losing more than half their value since a Tuesday ruling by District Judge William Young found the proposed deal could threaten competition in the U.S. aviation market and harm ticket prices. If the deal went through, it would have created the fifth-largest carrier in the United States and helped Spirit secure its survival. Following the ruling, some analysts said the carrier might contemplate a bankruptcy filing to streamline its balance sheet and reorganize into a financially robust airline.